Report Scope & Overview:
The Specialty PACS Market Size was valued at USD 3.09 billion in 2022, and expected to reach USD 5.15 billion by 2030, and grow at a CAGR of 6.6% over the forecast period 2023-2030.
PACS is a type of imaging technology that facilitates the transfer of images from the spot where they were captured to numerous physically distant sites. This technology is cost-effective since it eliminates the need for film and makes it simple to access several imaging modalities at once, including ultrasound, CT, MRI, and radiography, at different places throughout hospitals. Any radiological modality utilised for an image storage device or server for short- or long-term data storage is included in the integration of input from digital or digitised analogue instruments.
To get more information on Specialty PACS Market - Request Sample Report
The fact that a patient can have radiological tests done at many places without having to travel to see numerous radiologists or treating doctors is advantageous. Images captured by PACS are saved in an archive from whence they are retrieved or fetched and shown for review on a reviewing station after being integrated via network infrastructures.
Increasing Government Efforts to Promote the Use of Healthcare IT Solutions
Investments in Medical Imaging are Growing
Increasing Adoption of IT Solutions for Medical Imaging
Growing Use of Imaging Technology
Growing Geriatric Population and the Incidence of Various Diseases as a Result
Favorable Features of Specialty PACS
Concerns about data security and privacy
Artificial Intelligence and Specialty PACS Solutions Integration
Growth Prospects Provided by Cloud-Based Specialty PACS Solutions
EMR and PACS Integration
The utilization of blockchain in clinical imaging
Lack of awareness
IMPACT OF COVID-19
Numerous pharmaceutical firms and sectors were also affected by the COVID-19 pandemic. The COVID-19 pandemic outbreak has had an impact on the speciality PACS market, healthcare facilities, their supply chain, and decreased demand for PACS devices. Due to the closure of certain industries, it mostly affected big players in the speciality PACS market, who suffered financial losses. In general, COVID-19 had a detrimental effect on the speciality PACS market. This was linked to disruptions in manufacturing, raw material imports and export, and finished goods supply due to shutdowns in several COVID-19-affected nations and an increase in the number of healthcare workers getting sick from the pandemic. Additionally, a decrease in patient hospital visits had an effect on market expansion. Nevertheless, throughout the period following COVID-19, this condition is anticipated to alter.
The specialty PACS market is categorized into radiology PACS, cardiology PACS, pathology PACS, ophthalmology PACS, orthopedics PACS, oncology PACS, dermatology PACS, neurology PACS, endoscopy PACS, women’s health PACS, and other specialty PACS. The market's greatest share belonged to the radiology PACS sector, but the ophthalmology PACS segment is anticipated to grow at the highest CAGR throughout the forecast period. The increasing frequency of eye diseases and disorders, the growing number of ocular surgeries performed, and technical improvements in ophthalmology devices are some of the reasons driving the expansion of this market.
By Deployment Model
The market is split into on-premise and web/cloud-based specialty PACS. The on-premise category is likely to account for the greatest proportion of the market. This is explained by the fact that on-premise systems, as opposed to web/cloud-based specialist PACS, are more easily customized.
The hospital, the ambulatory surgical center (ASC), the clinic, the diagnostic center, and other sections of end users form a medical market. During forecasting, this segment is expected to grow rapidly due to a number of important factors, including increased patient numbers, increased patient awareness of the benefits of early diagnosis, technological advancement in thought processes, increased patient digital integration. data, and rapid growth in EMR acceptance.
Women’s health PACS
By Deployment Model
On-premise specialty PACS
Web/Cloud-based specialty PACS
Ambulatory Surgery Centers & Clinics
Diagnostic Imaging Centers
Need any customization research on Specialty PACS Market - Enquiry Now
Increasing medical imaging volumes, a large number of diagnostic imaging facilities, an ageing population, and the quick uptake of technologically advanced imaging systems are just a few of the factors that helped North America control the largest portion of the market. But during the course of the projection period, Asia Pacific is anticipated to develop at the greatest CAGR. The market in this region is expanding as a result of factors like the rising prevalence of chronic diseases, growing public awareness of the advantages of early disease diagnosis, and expanding use of imaging modalities.
Rest of Europe
Rest of Asia-Pacific
The Middle East & Africa
Rest of Middle East & Africa
Rest of Latin America
Some of the major key players are as follows: Canon Inc., McKesson Corporation, INC Escalon Medical Corp., Eye PACS, LLC, IBM Corporation, INFINITT Healthcare Co. Ltd., Novarad, Onex Corporation (Carestream Health), Siemens AG, Koninklijke Philips N.V. and Other Players
|Market Size in 2022||US$ 3.09 Billion|
|Market Size by 2030||US$ 5.15 Billion|
|CAGR||CAGR of 6.6% From 2023 to 230|
|Report Scope & Coverage||Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook|
|Key Segments||• By Type (Radiology PACS, Pathology PACS, Cardiology PACS, Ophthalmology PACS, Oncology PACS, Dermatology PACS, Orthopedics PACS, Endoscopy PACS, Neurology PACS, Women’s health PACS)
• By Deployment Model (On-premise specialty PACS, Web/Cloud-based specialty PACS)
• By End-User (Hospitals, Ambulatory Surgery Centers & Clinics, Diagnostic Imaging Centers)
|Regional Analysis/Coverage||North America (USA, Canada, Mexico), Europe
(Germany, UK, France, Italy, Spain, Netherlands,
Rest of Europe), Asia-Pacific (Japan, South Korea,
China, India, Australia, Rest of Asia-Pacific), The
Middle East & Africa (Israel, UAE, South Africa,
Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America)
|Company Profiles||anon Inc., McKesson Corporation, INC Escalon Medical Corp., Eye PACS, LLC, IBM Corporation, INFINITT Healthcare Co. Ltd., Novarad, Onex Corporation (Carestream Health), Siemens AG, Koninklijke Philips N.V.|
|DRIVERS||• Increasing Government Efforts to Promote the Use of Healthcare IT Solutions
• Investments in Medical Imaging are Growing
• Increasing Adoption of IT Solutions for Medical Imaging
|RESTRAINTS||• Concerns about data security and privacy
Ans: The market is expected to reach USD 5.15 billion by 2030.
Ans: The market is grown at a CAGR of 6.6% From 2023 to 2030.
Ans: The major players are Canon Inc., McKesson Corporation, INC Escalon Medical Corp., Eye PACS, LLC, IBM Corporation, INFINITT Healthcare Co. Ltd., Novarad, Onex Corporation (Carestream Health), Siemens AG, Koninklijke Philips N.V., and others in the final report.
Ans: The forecast period of the Specialty PACS Market is 2022-2030.
Table of Contents
1.1 Market Definition
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
4. Impact Analysis
4.1 COVID-19 Impact Analysis
4.2 Impact of Ukraine- Russia war
4.3 Impact of ongoing Recession
4.3.2 Impact on major economies
22.214.171.124 United Kingdom
126.96.36.199 South Korea
188.8.131.52 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Specialty PACS Market Segmentation, By Type
8.1 Radiology PACS
8.2 Pathology PACS
8.3 Cardiology PACS
8.4 Ophthalmology PACS
8.5 Oncology PACS
8.6 Dermatology PACS
8.7 Orthopedics PACS
8.8 Endoscopy PACS
8.9 Neurology PACS
8.10 Women’s health PACS
9. Specialty PACS Market Segmentation, By Deployment Model
9.1 On-premise specialty PACS
9.2 Web/Cloud-based specialty PACS
10. Specialty PACS Market Segmentation, By End-User
10.2 Ambulatory Surgery Centers & Clinics
10.3 Diagnostic Imaging Centers
11. Regional Analysis
11.2 North America
11.3.6 The Netherlands
11.3.7 Rest of Europe
11.4.2 South Korea
11.4.6 Rest of Asia-Pacific
11.5 The Middle East & Africa
11.5.3 South Africa
11.6 Latin America
11.6.3 Rest of Latin America
12.1 Canon Inc.
12.1.2 Products/ Services Offered
12.1.3 SWOT Analysis
12.1.4 The SNS view
12.2 INC Escalon Medical Corp.
12.3 Eye PACS, LLC
12.4 IBM Corporation
12.5 INFINITT Healthcare Co. Ltd.
12.6 Koninklijke Philips N.V.
12.7 McKesson Corporation
12.9 Onex Corporation (Carestream Health)
12.10 Siemens AG
13.1 Competitive Benchmark
13.2 Market Share Analysis
13.3 Recent Developments
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Risk-based Monitoring Software Market Size was valued at USD 8.20 billion in 2022, and is expected to reach USD 14.96 billion by 2030 and grow at a CAGR of 7.8% over the forecast period 2023-2030.
The Operating Room Management Market Size was valued at USD 2.89 billion in 2022, and is expected to reach USD 6.92 billion by 2030 and grow at a CAGR of 11.5% over the forecast period 2023-2030.
The Healthcare Data Storage Market Size was valued at USD 4.12 billion in 2022, and is expected to reach USD 12.17 billion by 2030, and grow at a CAGR of 14.5% over the forecast period 2023-2030.
The Digital Diabetes Management Market size was estimated USD 12.053 billion in 2022 and is expected to reach USD 22.47 billion by 2030 at a CAGR of 8.1% during the forecast period of 2023-2030.
The Tinnitus Management Market size was valued at USD 2.54 Billion in 2022 and is expected to grow to USD 3.34 Billion by 2030 and grow at a CAGR of 3.5% over the forecast period of 2023-2030.
The Over-The-Counter Drugs Market size was valued at USD 166 billion in 2022 and is expected to reach at USD 254 billion by 2030, and grow at a CAGR of 5.5% over the forecast period of 2023-2030.
Hi! Click one of our member below to chat on Phone